{"id":235692,"date":"2026-04-22T06:15:54","date_gmt":"2026-04-22T11:15:54","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/04\/this-study-refutes-the-hypothesis-that-coagulation-contributes-to-persistent-inflammation-in-treated-hiv"},"modified":"2026-04-22T06:15:54","modified_gmt":"2026-04-22T11:15:54","slug":"this-study-refutes-the-hypothesis-that-coagulation-contributes-to-persistent-inflammation-in-treated-hiv","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/04\/this-study-refutes-the-hypothesis-that-coagulation-contributes-to-persistent-inflammation-in-treated-hiv","title":{"rendered":"This study refutes the hypothesis that coagulation contributes to persistent inflammation in treated HIV"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/this-study-refutes-the-hypothesis-that-coagulation-contributes-to-persistent-inflammation-in-treated-hiv.jpg\"><\/a><\/p>\n<p><a href=\"https:\/\/doi.org\/10.1172\/jci.insight\">https:\/\/doi.org\/10.1172\/jci.insight<\/a>.<\/p>\n<p>Ivona Pandrea &amp; team report that adding factor Xa inhibitor (Apixaban) to ART had no discernible effect on the pathogenesis of SIV infection and did not reduce hypercoagulability and inflammation.<\/p>\n<hr>\n<p>\n<sup>1<\/sup>Department of Pathology and.<\/p>\n<p><sup>2<\/sup>Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.<\/p>\n<p><sup>3<\/sup>Department of Pathology and.<\/p>\n<p><sup>4<\/sup>Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2026\/04\/this-study-refutes-the-hypothesis-that-coagulation-contributes-to-persistent-inflammation-in-treated-hiv\">Continue reading \u201cThis study refutes the hypothesis that coagulation contributes to persistent inflammation in treated HIV\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>https:\/\/doi.org\/10.1172\/jci.insight. Ivona Pandrea &amp; team report that adding factor Xa inhibitor (Apixaban) to ART had no discernible effect on the pathogenesis of SIV infection and did not reduce hypercoagulability and inflammation. 1Department of Pathology and. 2Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 3Department of Pathology and. [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-235692","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=235692"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235692\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=235692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=235692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=235692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}